Free Trial
NASDAQ:TRAW

Traws Pharma (TRAW) Stock Price, News & Analysis

Traws Pharma logo
$2.34 +0.09 (+4.00%)
As of 02:04 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Traws Pharma Stock (NASDAQ:TRAW)

Advanced

Key Stats

Today's Range
$2.25
$2.46
50-Day Range
$1.33
$2.25
52-Week Range
$0.97
$19.44
Volume
230,535 shs
Average Volume
458,660 shs
Market Capitalization
$16.52 million
P/E Ratio
0.03
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

Traws Pharma Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
9th Percentile Overall Score

TRAW MarketRank™: 

Traws Pharma scored higher than 9% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Traws Pharma is 0.03, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 234.48.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Traws Pharma is 0.03, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 85.70.

  • Read more about Traws Pharma's valuation and earnings.
  • Percentage of Shares Shorted

    1.96% of the float of Traws Pharma has been sold short.
  • Short Interest Ratio / Days to Cover

    Traws Pharma has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Traws Pharma has recently increased by 16.96%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Traws Pharma does not currently pay a dividend.

  • Dividend Growth

    Traws Pharma does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.96% of the float of Traws Pharma has been sold short.
  • Short Interest Ratio / Days to Cover

    Traws Pharma has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Traws Pharma has recently increased by 16.96%, indicating that investor sentiment is decreasing significantly.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Traws Pharma this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Traws Pharma insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    13.60% of the stock of Traws Pharma is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 7.95% of the stock of Traws Pharma is held by institutions.

  • Read more about Traws Pharma's insider trading history.
Receive TRAW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Traws Pharma and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TRAW Stock News Headlines

GOLD ALERT
Gold has shattered records, soaring past $3,800 an ounce... But Stansberry Senior Partner Dr. David "Doc" Eifrig says history shows it could be on the verge of its biggest bull run in over half a century.tc pixel
Annovis Bio appoints CFO
Traws Pharma Completes Acquisition of Virom Assets
See More Headlines

TRAW Stock Analysis - Frequently Asked Questions

Traws Pharma's stock was trading at $8.88 on January 1st, 2025. Since then, TRAW shares have decreased by 73.8% and is now trading at $2.33.

Traws Pharma, Inc. (NASDAQ:TRAW) released its quarterly earnings data on Thursday, August, 14th. The company reported ($0.11) EPS for the quarter, topping the consensus estimate of ($8.75) by $8.64. The business earned $2.73 million during the quarter, compared to analyst estimates of $0.06 million. Traws Pharma had a negative trailing twelve-month return on equity of 1,812.48% and a net margin of 3,028.25%.
Read the conference call transcript
.

Shares of TRAW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Traws Pharma investors own include Clearside Biomedical (CLSD), Evofem Biosciences (EVFM), Sirius XM (SIRI), Adverum Biotechnologies (ADVM) and Aptinyx (APTX).

Company Calendar

Last Earnings
8/14/2025
Today
10/06/2025
Next Earnings (Estimated)
11/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:TRAW
Previous Symbol
NASDAQ:TRAW
CIK
1130598
Employees
17
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
$88.83
Trailing P/E Ratio
0.03
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$166.52 million
Net Margins
3,028.25%
Pretax Margin
-613.92%
Return on Equity
-1,812.48%
Return on Assets
512.72%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.09
Quick Ratio
2.09

Sales & Book Value

Annual Sales
$230 thousand
Price / Sales
71.52
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($8.66) per share
Price / Book
-0.27

Miscellaneous

Outstanding Shares
7,060,000
Free Float
6,103,000
Market Cap
$16.45 million
Optionable
Optionable
Beta
1.69
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:TRAW) was last updated on 10/6/2025 by MarketBeat.com Staff
From Our Partners